A Panel of Diverse Klebsiella pneumoniae Clinical Isolates for Research and Development

Klebsiella pneumoniae are a leading cause of healthcare associated infections worldwide. In particular, strains expressing extended-spectrum β-lactamases (ESBLs) and carbapenemases pose serious treatment challenges, leading the World Health Organization (WHO) to designate ESBL and carbapenem-resistant Enterobacteriaceae (CRE) as “critical” threats to human health. Research efforts to combat these pathogens can be supported by accessibility to diverse and clinically relevant isolates for testing novel therapeutics. Here, we describe a panel of 100 diverse K. pneumoniae isolates publicly available to assist the research community in this endeavor. Whole-genome sequencing (WGS) was performed on 3,878 K. pneumoniae clinical isolates housed at the Multidrug-Resistant Organism Repository and Surveillance Network. The isolates were cultured from 63 facilities in 19 countries between 2001 and 2020. Core-genome multilocus sequence typing and high-resolution single nucleotide polymorphism based phylogenetic analyses captured the genetic diversity of the collection and were used to select the final panel of 100 isolates. In addition to known multi-drug resistant (MDR) pandemic lineages, the final panel includes hypervirulent lineages and isolates with specific and diverse resistance genes and virulence biomarkers. A broad range of antibiotic susceptibilities ranging from pan-sensitive to extensively drug resistant isolates are described. The panel collection, all associated metadata and genome sequences, are available at no additional cost and will be an important for the research community and for the design and development of novel antimicrobial agents and diagnostics against this important pathogen. Importance Klebsiella pneumoniae is a major cause of healthcare-associated infections that are increasingly difficult to treat due to the emergence of multi-drug resistant strains. In particular, strains expressing extended-spectrum β-lactamases and carbapenemases have attained global notoriety, with the World Health Organization listing these strains as a “critical-priority” for the development of new therapeutics. Access to a diverse collection of strains for testing is critical for this endeavor, but few resources currently exist. Similarly, pivotal research of the genetic determinants underlying the pathogenesis of hypervirulent lineages is hampered by the lack of standardized, comparator strains. Herein we describe a panel of 100 diverse K. pneumoniae constructed to maximize genetic and phenotypic diversity from a repository of over 3,800 clinical isolates collected over 19 years. The panel, and all associated metadata and genome sequences, is provided at no cost and will greatly assist efforts by academic, government, and industry research groups.